CODMAN HAKIM - CODMAN HAKIM Programmable In-Line Valve with - CODMAN & SHURTLEFF, INC.

Duns Number:607846297

Device Description: CODMAN HAKIM Programmable In-Line Valve with Platform and Unitized 120cm Distal Catheter. CODMAN HAKIM Programmable In-Line Valve with Platform and Unitized 120cm Distal Catheter. Programmable in steps of 10mm H2O (98 Pa): 30mm H2O to 200mm H2O (294 Pa - 1960 Pa) Includes: Ventricular Catheter 14cm, Stylet, Right Angle Adapter, Atrial Connector, Straight Connector, Priming Adapter and Information Manual.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

NS0642

Brand Name

CODMAN HAKIM

Version/Model Number

NS0642

Device Commercial Distribution Status

Not in Commercial Distribution

Commercial Distribution End Date

September 01, 2022

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

MR Conditional

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K053350

Product Code Details

Product Code

JXG

Product Code Name

Shunt, central nervous system and components

Device Record Status

Public Device Record Key

3cc937f6-a160-4a5e-9b3b-1bffc38f80b0

Public Version Date

October 10, 2022

Public Version Number

5

DI Record Publish Date

September 20, 2015

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"CODMAN & SHURTLEFF, INC." Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 40
2 A medical device with a moderate to high risk that requires special controls. 1054
3 A medical device with high risk that requires premarket approval 11